Accelerate Diagnostics Inc.

4.29-0.0300-0.69%Vol 76.60K1Y Perf 423.13%
Dec 1st, 2023 15:59 DELAYED
BID4.21 ASK4.30
Open4.45 Previous Close4.32
Pre-Market- After-Market4.17
 - -  -0.12 -2.80%
Target Price
5.00 
Analyst Rating
Strong Buy 1.00
Potential %
16.55 
Finscreener Ranking
★★+     47.34
Insiders Trans % 3/6/12 mo.
-100/-100/78 
Value Ranking
★★     46.25
Insiders Value % 3/6/12 mo.
-100/-100/98 
Growth Ranking
★★★     50.28
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/93 
Income Ranking
 —    -
Price Range Ratio 52W %
5.93 
Earnings Rating
Strong Buy
Market Cap62.42M 
Earnings Date
9th Nov 2023
Alpha-0.03 Standard Deviation0.25
Beta1.08 

Today's Price Range

4.094.53

52W Range

3.8111.90

5 Year PE Ratio Range

-13.00-11.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-9.68%
1 Month
-27.90%
3 Months
-39.15%
6 Months
472.00%
1 Year
423.13%
3 Years
-44.57%
5 Years
-70.95%
10 Years
-68.82%

TickerPriceChg.Chg.%
AXDX4.29-0.0300-0.69
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
6.00
6.90
0.93
12.85
-12.10
Leverage Ratio -1.60
ProfitabilityValueIndustryS&P 500US Markets
-5.10
-495.70
-474.00
-1 072.90
-
RevenueValueIndustryS&P 500US Markets
9.78M
0.10
17.79
56.68
Earnings HistoryEstimateReportedSurprise %
Q02 2023-1.50-2.36-57.33
Q01 2023-1.70-1.700.00
Q04 2022-1.60-1.4012.50
Q03 2022-2.10-1.8014.29
Q02 2022--2.40-
Q01 2022-3.20-2.5021.88
Q04 2021-0.30-0.2323.33
Q03 2021-0.35-0.1557.14
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.6227.06Positive
12/2023 FY-4.6328.33Positive
3/2024 QR-0.5427.03Positive
12/2024 FY-2.0327.76Positive
Next Report Date-
Estimated EPS Next Report-0.94
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume76.60K
Shares Outstanding14.55K
Shares Float7.71M
Trades Count380
Dollar Volume326.78K
Avg. Volume23.81K
Avg. Weekly Volume33.95K
Avg. Monthly Volume18.84K
Avg. Quarterly Volume18.64K

Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock closed at 4.29 per share at the end of the most recent trading day (a -0.69% change compared to the prior day closing price) with a volume of 76.60K shares and market capitalization of 62.42M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 275 people. Accelerate Diagnostics Inc. CEO is John Phillips.

The one-year performance of Accelerate Diagnostics Inc. stock is 423.13%, while year-to-date (YTD) performance is 507.65%. AXDX stock has a five-year performance of -70.95%. Its 52-week range is between 3.81 and 11.9, which gives AXDX stock a 52-week price range ratio of 5.93%

Accelerate Diagnostics Inc. currently has a PE ratio of -0.70, a price-to-book (PB) ratio of 89.93, a price-to-sale (PS) ratio of 6.45, a price to cashflow ratio of 213.80, a PEG ratio of -, a ROA of -97.50%, a ROC of -51.28% and a ROE of 324.31%. The company’s profit margin is -%, its EBITDA margin is -474.00%, and its revenue ttm is $9.78 Million , which makes it $0.10 revenue per share.

Of the last four earnings reports from Accelerate Diagnostics Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.94 for the next earnings report. Accelerate Diagnostics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Accelerate Diagnostics Inc. is Strong Buy (1), with a target price of $5, which is +16.55% compared to the current price. The earnings rating for Accelerate Diagnostics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accelerate Diagnostics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accelerate Diagnostics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.43, ATR14 : 0.42, CCI20 : -107.21, Chaikin Money Flow : -0.48, MACD : -0.44, Money Flow Index : 9.71, ROC : -18.13, RSI : 28.57, STOCH (14,3) : 20.08, STOCH RSI : 0.51, UO : 35.77, Williams %R : -79.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accelerate Diagnostics Inc. in the last 12-months were: Brink Frank Jm Ten (Option Excercise at a value of $0), Brown Thomas (Option Excercise at a value of $0), Burris Wayne (Sold 0 shares of value $0 ), David Patience (Sold 0 shares of value $0 ), David Patience (Sold 4 040 shares of value $5 120 ), Francesconi Louise (Option Excercise at a value of $0), Frank J.M. Ten Brink (Option Excercise at a value of $0), Jack Phillips (Option Excercise at a value of $0), Jack Phillips (Sold 367 634 shares of value $180 362 ), Larry Michael Mertz (Option Excercise at a value of $0), Larry Michael Mertz (Sold 33 401 shares of value $16 366 ), Mark C. Miller (Option Excercise at a value of $0), Massarany Hany (Option Excercise at a value of $0), Miller Mark (Option Excercise at a value of $0), Patience David (Option Exercise at a value of $0), Patience David (Sold 92 shares of value $635 ), Phillips Jack (Option Excercise at a value of $0), Phillips Jack (Option Exercise at a value of $0), Phillips Jack (Sold 234 823 shares of value $148 345 ), Schuler Jack (Option Excercise at a value of $0), Steve Reichling (Option Excercise at a value of $0), Steve Reichling (Sold 77 039 shares of value $37 970 ), Steven Reichling (Option Excercise at a value of $0), Steven Reichling (Sold 77 039 shares of value $37 970 ), Watts Charles (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques.

CEO: John Phillips

Telephone: +1 520 365-3100

Address: 3950 South Country Club Road, Tucson 85714, AZ, US

Number of employees: 275

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

57%43%

Bearish Bullish

57%43%

 

TipRanks News for AXDX

Mon, 27 Nov 2023 14:16 GMT Accelerate Diagnostics announces collaboration with Bruker

- TipRanks. All rights reserved.

News

Stocktwits